World Journal of Nuclear Medicine : Table of Contents

Home

About us

Editorial board

Ahead of print

Current issue

Archives

Submit article

Instructions

Contacts

Users Online: 109

Article Cited by others

ORIGINAL ARTICLE

Standard Operating Procedure for In-house Preparation of ¹³¹ I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma

Pickford Matthew D, Turner J Harvey

Year : 2012| Volume: 11| Issue : 3 | Page no: 105-109

This article has been cited by

1	A Pioneer Experience In Malaysia On In-house Radio-labelling of 131I-Rituximab In The Treatment Of Non-Hodgkinæs Lymphoma And A Case Report of High Dose 131I-Rituximab-BEAM Conditioning Autologous Transplant

	Jew Win Kuan,Chiong Soon Law,Xiang Qi Wong,Ching Tiong Ko,Zool Hilmi Awang,Lee Ping Chew,Kian Meng Chang

	Applied Radiation and Isotopes. 2016;

	[Pubmed] [Google Scholar] [DOI]

2	Standard Operating Procedure for Prospective Individualised Dosimetry for[131]I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma

	JHarvey Turner,PhillipeJ Calais

	World Journal of Nuclear Medicine. 2012; 11(3): 110

	[Pubmed] [Google Scholar] [DOI]